HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Research Dictionary Pharma Mobile

Sign Up FREE or Login

eremomycin

Subscribe to New Research on eremomycin

Also Known As:

8-82846B; A 82846A; A82846A; Eremomycin

Networked: 6 relevant articles (3 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Carbohydrates: 4088
- Glycoconjugates: 716
  - Glycopeptides: 650
    - eremomycin: 6
Amino Acids, Peptides, and Proteins
- Peptides: 22950
  - Glycopeptides: 650
    - eremomycin: 6

Related Diseases

1.	Sepsis (Septicemia) 05/01/1989 - "The chemotherapeutic indices of eremomycin in treatment of staphylococcal and streptococcal sepsis in albino mice exceeded 10 times those of vancomycin. " 01/01/1989 - "By the therapeutic efficacy in albino mice with staphylococcal or streptococcal sepsis eremomycin was 2-4 times as superior as vancomycin and ristomycin and by the chemotherapeutic indices it was more than 10 times as superior." 11/01/1990 - "Chemotherapeutic efficacy of eremomycin in combination with tobramycin was investigated on a model of experimental sepsis of albino mice caused by Staphylococcus aureus cultures resistant to methicillin. "
2.	Pseudomembranous Enterocolitis (Pseudomembranous Colitis) 03/01/1992 - "The efficacy of eremomycin, a new glycopeptide antibiotic, was studied on a model of antibiotic-associated colitis in golden hamsters. " 03/01/1992 - "[Eremomycin in the treatment of antibiotic-associated colitis in golden hamsters]." 11/01/1992 - "[Comparative study of the therapeutic effect of the glycopeptide antibiotics eremomycin, vancomycin and ristomycin in a model of antibiotic-associated colitis in golden hamsters]." 11/01/1992 - "Experiments with a model of intraperitoneal or intragastric lincomycin-induced fatal colitis indicated that eremomycin, vancomycin and ristomycin administered orally in daily doses of 100, 100 and 200 mg/kg, respectively, for 5 days protected the animals from development of antibiotic-associated colitis (AAC), which was evident from prolongation of their life-span to 10-23 days against 3-9 days in the controls. "
3.	Colitis 03/01/1992 - "In a dose of 100 mg/kg administered orally once a day for 5 days eremomycin protected the animals from the lincomycin-induced colitis: some animals survived, the others died in later periods. " 11/01/1992 - "Experiments with a model of intraperitoneal or intragastric lincomycin-induced fatal colitis indicated that eremomycin, vancomycin and ristomycin administered orally in daily doses of 100, 100 and 200 mg/kg, respectively, for 5 days protected the animals from development of antibiotic-associated colitis (AAC), which was evident from prolongation of their life-span to 10-23 days against 3-9 days in the controls. "
4.	Infection 08/01/1987 - "Eremomycin is less toxic than vancomycin whereas its chemotherapeutic activity in treatment of infections caused by gram-positive organisms is higher."

Related Drugs and Biologics

1.	Vancomycin
2.	Ristocetin
3.	Tobramycin (Nebcin)
4.	Methicillin (Metin)
5.	Lincomycin (Lincocin)
6.	Anti-Bacterial Agents (Antibiotics)